Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · IEX Real-Time Price · USD
3.080
-0.100 (-3.14%)
At close: Jul 19, 2024, 4:00 PM
3.100
+0.020 (0.65%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Harvard Bioscience Market Cap

Harvard Bioscience has a market cap or net worth of $133.76 million as of July 22, 2024. Its market cap has decreased by -42.66% in one year.

Market Cap
133.76M
Enterprise Value
170.87M
1-Year Change
-42.66%
Ranking
Category
Stock Price
$3.08

Market Cap Chart

Since March 19, 2001, Harvard Bioscience's market cap has decreased from $173.50M to $133.76M, a decrease of -22.90%. That is a compound annual growth rate of -1.11%.

History

DateMarket Cap% Change
Jul 19, 2024133.80M-41.42%
Dec 29, 2023228.40M97.92%
Dec 30, 2022115.40M-59.89%
Dec 31, 2021287.70M72.07%
Dec 31, 2020167.20M44.01%
Dec 31, 2019116.10M-2.11%
Dec 31, 2018118.60M3.04%
Dec 29, 2017115.10M9.83%
Dec 30, 2016104.80M-11.04%
Dec 31, 2015117.80M-35.91%
Dec 31, 2014183.80M26.15%
Dec 31, 2013145.70M15.45%
Dec 31, 2012126.20M14.42%
Dec 30, 2011110.30M-4.42%
Dec 31, 2010115.40M9.70%
Dec 31, 2009105.20M29.08%
Dec 31, 200881.50M-42.24%
Dec 31, 2007141.10M-9.96%
Dec 29, 2006156.70M15.56%
Dec 30, 2005135.60M-3.49%
Dec 31, 2004140.50M-47.56%
Dec 31, 2003267.90M170.88%
Dec 31, 200298.90M-62.67%
Dec 31, 2001264.90M52.68%
Mar 19, 2001173.50M-
View and export this data all the way back to 2001. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Corvus Pharmaceuticals 136.36M
Electromed 136.24M
Inventiva 136.16M
CervoMed 134.12M
DIH Holdings US 133.80M
Tevogen Bio Holdings 133.36M
Veru Inc. 132.29M
Compass Therapeutics 128.89M
Market Cap Rankings